Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

TLR4/MD-2 Antikörper

Dieses Anti-TLR4/MD-2-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von TLR4/MD-2 in FACS und InhA. Geeignet für Human.
Produktnummer ABIN2192088

Kurzübersicht für TLR4/MD-2 Antikörper (ABIN2192088)

Target

TLR4/MD-2 (TLR4/LY96) (TLR4/LY96 Complex (TLR4/LY96))

Reaktivität

Human

Wirt

Maus

Klonalität

Monoklonal

Applikation

Flow Cytometry (FACS), Inhibition Assay (InhA)

Klon

7E3
  • Sterilität

    0.2 μm filtered

    Immunogen

    TLR4/MD-2 expressing CHO cells/ chimeric TLR4/MD-2 fusion protein
  • Applikationshinweise

    For flow cytometry, dilutions to be used depend on detection system applied. It is recommended that users test the reagent and determine their own optimal dilutions. The typical starting working dilution is 1:50. For functional studies dilutions have to be made according to the amounts of MD-2 to be inactivated.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Buffer

    PBS, containing 0.1 % bovine serum albumin.

    Lagerung

    4 °C

    Informationen zur Lagerung

    Product should be stored at 4 °C. Under recommended storage conditions, product is stable for one year.

    Haltbarkeit

    12 months
  • Target

    TLR4/MD-2 (TLR4/LY96) (TLR4/LY96 Complex (TLR4/LY96))

    Andere Bezeichnung

    Tlr4/md-2

    Hintergrund

    The monoclonal antibody 7E3 reacts with the Toll-like receptor 4 (TLR4, CD284)/MD-2 complex. TLRs belong to a family of proteins that specifically recognizes and senses microbial products. They are highly conserved throughout evolution and act as innate immune recognition receptors against many pathogens. TLR4 is a functional receptor for gram-negative bacterial lipopolysaccharides (LPS). TLR4 associates with MD-2 which is absolutely required for LPS-induced activation of TLR4. MD-2 exists as a cell surface protein in association with TLR4. It also exists as secreted forms consisting of MD-2 monomers and multimers (sMD-2). Circulating sMD-2 is mainly present as a doublet of ~20 and 25 kD, representing differentially glycosylated forms. Unlike TLR4, sMD-2 binds directly LPS without the need of soluble CD14 (sCD14). However, LPS-MD-2 interactions are increased when LPS is pretreated with CD14. Only monomeric sMD-2 is biologically active and able to associate with TLR4 and LPS. sMD-2 circulates in plasma of healthy individuals as a non-active, polymeric protein. In septic plasma, the total amount of sMD-2 was strongly elevated and contained both sMD-2 polymers and monomers. Soluble MD-2 is proposed to be an important mediator of organ inflammation during sepsis. During experimental human endotoxemia, the monomeric and total sMD-2 content in plasma increased with the kinetics of an acute phase protein. This parallels enhanced TLR4 costimulatory activity. In vitro studies revealed that sMD-2 release appears to be restricted to endothelial and dendritic cells. The monoclonal antibody 7E3 reacts with the TLR4/MD-2 complex and is able to inhibit the biological activity of the TLR4/MD-2 complex. Aliases CD284 / Lymphocyte antigen 96, ESOP-1, LY96
Sie sind hier:
Chat with us!